⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Atara Biotherapeutics, Inc

$9.38
-0.06 (-0.64%)

Market Capitalization:

$94.15M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Atara Biotherapeutics, Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$9.38
Close$9.38
Low$9.38
Low Change0.00 (0.00%)
High$9.38
High Change+0.00 (+0.00%)
Range$0.00
Volume964
Dollar Volume$9.04K

Regular Trading Hours Yesterday

-0.56(-5.60%)
Open$10.00
Close$9.44
Low$9.40
Low Change-0.60 (-6.00%)
High$10.00
High Change+0.00 (+0.00%)
Range$0.60
Volume10.042K
Dollar Volume$94.80K

Premarket Yesterday

*No Trades in Segment

Atara Biotherapeutics, News

There is no current news for this stock at the moment.

Atara Biotherapeutics, Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Atara Biotherapeutics, Moving Averages

5 Day Moving Average (SMA5)$9.87
10 Day Moving Average (SMA10)$9.53
20 Day Moving Average (SMA20)$9.39
50 Day Moving Average (SMA50)$9.04
100 Day Moving Average (SMA100)$8.94
200 Day Moving Average (SMA200)$8.76

Atara Biotherapeutics, Statistics

Average Volume (30 Days)51.1K
P/E Ratio (Current)-5.96
EPS (Current)-$1.66
Dividend Yield0.00%
Free Cash Flow-$21.90M
Cash Ratio0.47
Current Ratio1.98
Quick Ratio1.98
Debt to Equity0.00
Enterprise Value$96.05M
EV to EBITDA-6.81
EV to Sales15.51
Price to Book-2.68
Price to Cash Flow
Price to Free Cash Flow
Price to Sales16.03
Return on Assets-0.79%
Return on Equity0.45%

Atara Biotherapeutics, Stock Splits

There has been 1 stock split for Atara Biotherapeutics, (ATRA). The reverse stock split occured on June 20, 2024 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
Jun 20, 2024Reverse25:1

Atara Biotherapeutics, Dividends

There have been no dividends for Atara Biotherapeutics, (ATRA).